The impact of utilization of early aneuploidy screening on amniocenteses available for training in obstetrics and fetal medicine
Open Access
- 27 January 2013
- journal article
- Published by Wiley in Prenatal Diagnosis
- Vol. 33 (3) , 242-244
- https://doi.org/10.1002/pd.4052
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Chromosomal Microarray versus Karyotyping for Prenatal DiagnosisNew England Journal of Medicine, 2012
- Genome-Wide Fetal Aneuploidy Detection by Maternal Plasma DNA SequencingObstetrics & Gynecology, 2012
- DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation studyGenetics in Medicine, 2011
- Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical settingAmerican Journal of Obstetrics and Gynecology, 2011
- ACOG Practice Bulletin No. 107: Induction of LaborObstetrics & Gynecology, 2009
- Revisiting the Fetal Loss Rate After Second-Trimester Genetic AmniocentesisObstetrics & Gynecology, 2008
- First-Trimester or Second-Trimester Screening, or Both, for Down's SyndromeNew England Journal of Medicine, 2005
- Integrated Screening for Down's Syndrome Based on Tests Performed during the First and Second TrimestersNew England Journal of Medicine, 1999
- Reducing the Need for Amniocentesis in Women 35 Years of Age or Older with Serum Markers for ScreeningNew England Journal of Medicine, 1994
- RANDOMISED CONTROLLED TRIAL OF GENETIC AMNIOCENTESIS IN 4606 LOW-RISK WOMENPublished by Elsevier ,1986